logo

For the Inventor, By the Inventor

Lausanne, Switzerland

Rolland-Yves Mauvernay

This inventor holds 10 USPTO granted patents and 1 EPO patent. Top assignees: Debiopharm S.a., Debio Recherche Pharmaceutique S.a., Other. Active years: 1987-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolland-Yves Mauvernay. Retrieved from https://idiyas.com/inventor/rolland-yves-mauvernay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 80.0


Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 258(Granted Patents)


Location History:

  • Lausanne, CH (1987 - 2000)
  • Lausańne, CH (2005)
  • Prez-vers-Siviriez, Fribourg, CH (2008 - 2010)
  • Champ du Moulin, CH (2012)

Company Filing History:

goldMedal6 out of 28 
 
Debiopharm S.a.
 patents
silverMedal1 out of 15 
 
Debio Recherche Pharmaceutique S.a.
 patents
bronzeMedal3 out of 834,570 
Other
 patents

Years Active: 1987-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 8211940 - Oxaliplatin active substance with a very low content of oxalic acid (2012-07-03),
2. 7772184 - Use of a cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said cyclosporin (2010-08-10),
3. 7439227 - Use of selected cyclosporins for the treatment of hepatitis C infection (2008-10-21),
4. 6866857 - Oxalipatinum preparation packaging (2005-03-15),
5. 6153646 - Binuclear platinum complexes, method for preparing same and (2000-11-28),
6. 5776885 - Sustained and controlled release of water insoluble polypeptides (1998-07-07),
7. 5716988 - Pharmaceutically stable preparation of oxaliplatinum (1998-02-10),
8. 5635515 - Therapeutic agents for the treatment of multiple drug resistance of (1997-06-03),
9. 5192741 - Sustained and controlled release of water insoluble polypeptides (1993-03-09),
10. 4673595 - Microencapsulation by phase separation of water-soluble medicaments (1987-06-16),

Title: Rolland-Yves Mauvernay: Innovator in Pharmaceutical Chemistry

Introduction

Rolland-Yves Mauvernay is a distinguished inventor based in Lausanne, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on innovative solutions for medical treatments.

Latest Patents

Among his latest patents is an oxaliplatin active substance with a very low content of oxalic acid. This invention relates to a pharmaceutical composition where the weight content of oxalic acid does not exceed 0.08%. Additionally, he has developed a method for using cyclosporin in the treatment of hepatitis C infection. This invention involves a cyclosporin that has increased cyclophilin binding activity while essentially lacking immunosuppressive effects.

Career Highlights

Throughout his career, Rolland-Yves Mauvernay has worked with notable companies, including Debiopharm S.A. His innovative approaches have led to advancements in pharmaceutical formulations and treatments.

Collaborations

He has collaborated with esteemed colleagues such as Piero Orsolini and Romano Deghenghi, contributing to a rich exchange of ideas and expertise in the pharmaceutical industry.

Conclusion

Rolland-Yves Mauvernay's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact medical treatments and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…